The first ALS patient has been enrolled in an NIH-funded expanded access program trial evaluating MN-166 (ibudilast).

The ‘Euphoria’ actor revealed in 2025 that he was diagnosed with the disease known as ALS. Learn about his condition and ...

TRE-515, a small molecule inhibitor of deoxycytidine kinase, is being developed for autoimmune diseases and in clinical ...

In a phase 3, open-label safety extension study, researchers evaluated the safety of oral edaravone in patients with amyotrophic lateral sclerosis over 96 weeks.

in patients with Amyotrophic Lateral Sclerosis (ALS). This significant milestone marks the beginning of a critical trial aimed at providing access to MN-166 for ALS patients who are not eligible for ...

When actor Eric Dane revealed his diagnosis of amyotrophic lateral sclerosis (ALS), the world took notice. Novant Health ...

Actor Eric Dane recently announced that he has been diagnosed with amyotrophic lateral sclerosis (ALS), a degenerative and ...

Amyotrophic_Lateral_Sclerosis_Market_ MRFR reveals steady growth in the ALS market, projecting an increase from $0.94 billion in 2023 to $1 ...

Actor Eric Dane, known for Grey's Anatomy and Euphoria, has revealed his diagnosis with Amyotrophic Lateral Sclerosis (ALS), ...

The Patient-Centered Outcomes Research Institute (PCORI) has announced funding for new patient-centered comparative clinical ...

ALS, or amyotrophic lateral sclerosis, is a fatal neurodegenerative ... to raising awareness and critical funds for ALS research, patient care, and support services. To learn more about ALS ...

in patients with Amyotrophic Lateral Sclerosis (ALS). This significant milestone marks the beginning of a critical trial aimed at providing access to MN-166 for ALS patients who are not eligible ...